Taipei, Taiwan

May-Jywan Tsai

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Taipei Veterans General Hospital. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: May-Jywan Tsai. Retrieved from https://idiyas.com/inventor/may-jywan-tsai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: May-Jywan Tsai: Innovator in Neural Injury Treatment

Introduction

May-Jywan Tsai is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical treatment, particularly in the area of neural injuries. His innovative approach focuses on the use of natural compounds to enhance recovery from such injuries.

Latest Patents

May-Jywan Tsai holds a patent for the "Use of silymarin and silybin in the treatment of neural injury." This invention provides a method for treating neural injuries, such as spinal cord injury (SCI), by utilizing silymarin or silybin to enhance recovery. The patent highlights the potential of these compounds in promoting healing and recovery in patients suffering from neural damage.

Career Highlights

Tsai is affiliated with Taipei Veterans General Hospital, where he conducts research and applies his innovative methods in clinical settings. His work has garnered attention for its potential to improve patient outcomes in the treatment of neural injuries.

Collaborations

May-Jywan Tsai collaborates with Henrich Cheng, a fellow researcher who contributes to his projects. Their partnership enhances the research efforts and broadens the scope of their work in the field of neural injury treatment.

Conclusion

May-Jywan Tsai's contributions to the treatment of neural injuries through his innovative use of silymarin and silybin represent a significant advancement in medical science. His work at Taipei Veterans General Hospital continues to pave the way for improved recovery methods for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…